Abstract
BackgroundUnder the National Childhood Immunisation Schedule (NCIS) in Singapore most vaccines are provided free while some, including pneumococcal conjugate vaccines (PCV), added to the NCIS in October 2009, are not free. In contrast to ≥95 % coverage achieved for recommended childhood vaccines that are free, 2013 coverage of the PCV booster dose was 58.9 % (for unclear reasons). To date, no population impact on pneumococcal disease (PD) has been observed. We conducted a questionnaire-based study of parents of young children to assess the value of PCV to parents, and to quantify the extent to which vaccine cost is a barrier to PCV uptake in Singapore.MethodsA single, trained interviewer administered a questionnaire to 200 parents ≥21 years of age with young children attending the Singapore Sengkang Polyclinic. The questionnaire asked closed-ended questions on parents’ knowledge about PD and PCV. A 5-point Likert scale measured perceived benefits and barriers to PCV vaccination.ResultsThere were 162 parents whose children were either PCV-vaccinated or who intended to vaccinate their child with PCV (Vaccinated group), and 38 whose children were non-PCV vaccinated or who did not intend to vaccinate (Unvaccinated group). The odds ratio for PCV vaccination among parents who perceived cost as a barrier was 0.16 (95%CI 0.02–1.23). Compared to the Vaccinated group, parents in the Unvaccinated group were less willing to pay for PCV (50.0 %/94.4 %). Compared to the Vaccinated group, fewer parents in the Unvaccinated group had heard about PD (34.2 %/82.1 %) or PCV (36.8 %/69.1 %), or perceived that PD was a threat to their child. Fewer parents in the Unvaccinated group knew that vaccination could prevent PD (28.9 %/77.8 %), or reported that PCV vaccination was recommended to them by any source (63.2 % had no PCV recommendation, versus 20.4 %). When informed that PCV is included in the NCIS only 65.8 % of parents in the Unvaccinated group, versus 98.8 % in the Vaccinated group, indicated that they would be willing to vaccinate their child.ConclusionsCost considerations, not having vaccination recommended to parents and a lack of knowledge among parents of the benefits of PCV to the child may adversely impact PCV uptake in Singapore.Electronic supplementary materialThe online version of this article (doi:10.1186/s12889-016-3597-5) contains supplementary material, which is available to authorized users.
Highlights
Under the National Childhood Immunisation Schedule (NCIS) in Singapore most vaccines are provided free while some, including pneumococcal conjugate vaccines (PCV), added to the NCIS in October 2009, are not free
Statistical analysis There were two study groups: those parents whose children were either PCV-vaccinated or who intended to vaccinate their child with PCV (Vaccinated group), and those parents whose children were not vaccinated with PCV, or who did not intend to vaccinate their child with PCV (Unvaccinated group)
Compared to parents in the Vaccinated group, parents in the Unvaccinated group were less willing to pay for PCV vaccination (94.4 % Vaccinated, 50.0 % Unvaccinated) (Table 2)
Summary
Under the National Childhood Immunisation Schedule (NCIS) in Singapore most vaccines are provided free while some, including pneumococcal conjugate vaccines (PCV), added to the NCIS in October 2009, are not free. Licensed pneumococcal conjugate vaccines (PCVs) have proven to be highly effective in preventing morbidity and mortality due to Invasive Pneumococcal Disease (IPD), pneumonia and otitis media in children, with evidence of herd protection in unvaccinated age groups [3, 4]. Prior to the availability of PCVs in Singapore (2005), the annual incidence of hospitalised “pneumococcal disease” (defined using the International Classification of Disease ICD-9 codes that included pneumococcal pneumonia, meningitis, peritonitis, septicaemia and a less specific code for pneumococcal bacterial infection in unspecified sites) among children
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.